Skip to main content
VMD
NASDAQ Life Sciences

Viemed Healthcare Reports Q4 Revenue of $76.18M, Net Income $5.82M

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$9.08
Mkt Cap
$345.203M
52W Low
$5.93
52W High
$9.201
Market data snapshot near publication time

summarizeSummary

Viemed Healthcare has released its fourth-quarter financial results, reporting revenue of $76.181 million, gross profit of $44.103 million, and net income of $5.816 million. These figures provide the market with the company's latest operational performance metrics. While the brief report does not include comparisons to analyst estimates or prior periods, these core financial results are critical for traders to update their valuation models and assess the company's trajectory. Investors will now await the full earnings call and detailed report for management commentary and forward-looking guidance.

At the time of this announcement, VMD was trading at $9.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $345.2M. The 52-week trading range was $5.93 to $9.20. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed VMD - Latest Insights

VMD
Apr 22, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
VMD
Mar 20, 2026, 5:06 PM EDT
Filing Type: 4
Importance Score:
8
VMD
Mar 20, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
VMD
Mar 19, 2026, 4:11 PM EDT
Filing Type: 144
Importance Score:
7
VMD
Mar 16, 2026, 4:51 PM EDT
Filing Type: 8-K
Importance Score:
7
VMD
Mar 04, 2026, 4:50 PM EST
Filing Type: 10-K
Importance Score:
8
VMD
Mar 04, 2026, 4:45 PM EST
Source: Reuters
Importance Score:
7
VMD
Feb 02, 2026, 5:35 PM EST
Filing Type: 4
Importance Score:
8
VMD
Feb 02, 2026, 5:35 PM EST
Filing Type: 4
Importance Score:
7
VMD
Feb 02, 2026, 5:34 PM EST
Filing Type: 4
Importance Score:
7